Molecularly targeted protease-activated probes for visualization of glioblastoma: a comparison with 5-ALA. Konečná D, Výmola P, Ternerová N, Výmolová B, Garcia-Borja E, Mateu R, Šroubek F, Pankrác J, Widen JC, Bogyo M, Netuka D, Bušek P, Šedo J Neurosurg. 2024 Mar 29:1-12. doi: 10.3171/2024.1.JNS231137, PMID: 38552239.
Critical appraisal of the piRNA-PIWI axis in cancer and cancer stem cells. Garcia-Borja E, Siegl F, Mateu R, Slaby O, Sedo A, Busek P, Sana J. Biomark Res. 2024 Feb 1;12(1):15. doi: 10.1186/s40364-024-00563-3. PMID: 38303021; PMCID: PMC10836005.
Combination of quinoxaline with pentamethinium system: Mitochondrial staining and targeting. Kejík Z, Koubková N, Krčová L, Sýkora D, Abramenko N, Veselá K, Kaplánek R, Hajduch J, Houdová Megová M, Bušek P, Šedo A, Lacina L, Smetana K Jr, Martásek P, Jakubek M. Bioorg Chem. 2023 Dec;141:106816. doi: 10.1016/j.bioorg.2023.106816. Epub 2023 Sep 9. PMID: 37716274.
Fibroblast
activation protein as a potential theranostic target in brain metastases
of diverse solid tumours. Zubaľ M, Výmolová B, Matrasová I, Výmola P, Vepřková J, Syrůček M, Tomáš
R, Vaníčková Z, Křepela E, Konečná D, Bušek P, Šedo A. Pathology. 2023 Jun 16:S0031-3025(23)00137-X.
doi: 10.1016/j.pathol.2023.05.003. PMID: 37419841.
New-Generation Heterocyclic Bis-Pentamethinium Salts as Potential Cytostatic Drugs with Dual IL-6R and Mitochondria-Targeting Activity. Talianová V, Kejík Z, Kaplánek R, Veselá K, Abramenko N, Lacina L, Strnadová K, Dvořánková B, Martásek P, Masařík M, Megová MH, Bušek P, Křížová J, Zdražilová L, Hansíková H, Vlčák E, Filimonenko V, Šedo A, Smetana K Jr, Jakubek M. Pharmaceutics. 2022 Aug 17;14(8):1712. doi: 10.3390/pharmaceutics14081712. PMID: 36015338; PMCID: PMC9416741.
Does DPP-IV Inhibition Offer New Avenues for Therapeutic Intervention in Malignant Disease? Busek P, Duke-Cohan JS, Sedo A. Cancers (Basel). 2022 Apr 21;14(9):2072. doi: 10.3390/cancers14092072. PMID: 35565202; PMCID: PMC9103952.
Autoimmunity, cancer and COVID-19 abnormally activate wound healing pathways: critical role of inflammation.Gál P, Brábek J, Holub M, Jakubek M, Šedo A, Lacina L, Strnadová K, Dubový P, Hornychová H, Ryška A, Smetana K Jr. Histochem Cell Biol. 2022 Nov;158(5):415-434. doi: 10.1007/s00418-022-02140-x. Epub 2022 Jul 22. PMID: 35867145; PMCID: PMC9305064.
Fibroblast Activation Protein Expressing Mesenchymal Cells Promote Glioblastoma Angiogenesis.Balaziova E, Vymola P, Hrabal P, Mateu R, Zubal M, Tomas R, Netuka D, Kramar F, Zemanova Z, Svobodova K, Brabec M, Sedo A, Busek P. Cancers (Basel). 2021 Jul 1;13(13):3304. doi: 10.3390/cancers13133304. PMID: 34282761; PMCID: PMC8267680.
Regulation of Fibroblast Activation Protein by Transforming Growth Factor Beta-1 in Glioblastoma Microenvironment. Krepela E, Vanickova Z, Hrabal P, Zubal M, Chmielova B, Balaziova E, Vymola P, Matrasova I, Busek P, Sedo A. Int J Mol Sci. 2021 Jan 21;22(3):1046. doi: 10.3390/ijms22031046. PMID: 33494271; PMCID: PMC7864518.
Molecular recognition of fibroblast activation protein for diagnostic and therapeutic applications. Šimková A, Bušek P, Šedo A, Konvalinka J. Biochim Biophys Acta Proteins Proteom. 2020 Jul;1868(7):140409. doi: 10.1016/j.bbapap.2020.140409. Epub 2020 Apr 6. PMID: 32171757.
Identification of microRNAs differentially expressed in glioblastoma stem-like cells and their association with patient survival.Sana J, Busek P, Fadrus P, Besse A, Radova L, Vecera M, Reguli S, Stollinova Sromova L, Hilser M, Lipina R, Lakomy R, Kren L, Smrcka M, Sedo A, Slaby O. Sci Rep. 2018 Feb 12;8(1):2836. doi: 10.1038/s41598-018-20929-6. PMID: 29434344; PMCID: PMC5809429.
Targeting fibroblast activation protein in cancer - Prospects and caveats. Busek P, Mateu R, Zubal M, Kotackova L, Sedo A. . Front Biosci (Landmark Ed). 2018 Jun 1;23(10):1933-1968. doi: 10.2741/4682. PMID: 29772538.
Fibroblasts potentiate melanoma cells in vitro invasiveness induced by UV-irradiated keratinocytes. Jobe NP, Živicová V, Mifková A, Rösel D, Dvořánková B, Kodet O, Strnad H, Kolář M, Šedo A, Smetana K Jr, Strnadová K, Brábek J, Lacina L. . Histochem Cell Biol. 2018 May;149(5):503-516. doi: 10.1007/s00418-018-1650-4. Epub 2018 Feb 12. PMID: 29435761.
Inhibitor-Decorated Polymer Conjugates Targeting Fibroblast Activation Protein.Dvořáková P, Bušek P, Knedlík T, Schimer J, Etrych T, Kostka L, Stollinová Šromová L, Šubr V, Šácha P, Šedo A, Konvalinka J. J Med Chem. 2017 Oct 26;60(20):8385-8393. doi: 10.1021/acs.jmedchem.7b00767. Epub 2017 Oct 16. PMID: 28953383.
Heterogeneity of molecular forms of dipeptidyl peptidase-IV and fibroblast activation protein in human glioblastomas. Matrasova I, Busek P, Balaziova E, Sedo A. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2017 Sep;161(3):252-260. doi: 10.5507/bp.2017.010. Epub 2017 Apr 26. PMID: 28452380.
Species-specific real-time RT-PCR analysis of expression of stromal cell genes in a tumor xenotransplantation model in mice. Krepela E, Busek P, Hilser M, Vanickova Z, Sedo A. . Biochem Biophys Res Commun. 2017 Sep 9;491(1):126-133. doi: 10.1016/j.bbrc.2017.07.061. Epub 2017 Jul 12. PMID: 28711492.
Early detection of sporadic pancreatic cancer: time for change.Frič P, Šedo A, Škrha J, Bušek P, Laclav M, Škrha P, Zavoral M. . Eur J Gastroenterol Hepatol. 2017 Aug;29(8):885-891. doi: 10.1097/MEG.0000000000000904. PMID: 28471824.